Australian Bauxite Ltd (ASX:ABX) CEO Revised Presentation
In accordance with the requirements of Listing Rule 3.1 Australian Bauxite Ltd (ASX:ABX) submit the attached material that was presented at the 2018 Mining Resources Convention.
In accordance with the requirements of Listing Rule 3.1 Australian Bauxite Ltd (ASX:ABX) submit the attached material that was presented at the 2018 Mining Resources Convention.
Australian Bauxite Ltd (ASX:ABX) provides the Company's Quarterly Report.
The Board of Queensland Bauxite Limited (ASX:QBL) is very pleased to announce a materially strategic transaction, that its soon to be wholly owned subsidiary Medcan Australia, has entered into a Strategic Collaboration and Supply Agreement Signed with an established Canadian Licensed Producer of Medical Cannabis.
Queensland Bauxite Ltd (ASX:QBL) provides the Company's Annual Report to shareholders.
The Board of Queensland Bauxite Limited (ASX:QBL) is very pleased to announce a materially strategic transaction, that its soon to be wholly owned subsidiary Medcan Australia, has entered into a memorandum of understanding with top Israeli medicinal cannabis company Pharmocann.
This attached supplementary prospectus of Queensland Bauxite Ltd (ASX:QBL) has included some updated information on the original prospectus that was lodged with the ASIC on 27 September 2018.
In accordance with the requirements of Listing Rule 3.1 Australian Bauxite Ltd (ASX:ABX) submit the attached material is being presented at the 2018 Mining Resources Convention.